Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$431M |
| 2 |
NVIDIA
NVDA
|
+$220M |
| 3 |
Micron Technology
MU
|
+$182M |
| 4 |
Union Pacific
UNP
|
+$168M |
| 5 |
Southern Company
SO
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$459M |
| 2 |
Meta Platforms (Facebook)
META
|
+$403M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$380M |
| 4 |
Salesforce
CRM
|
+$271M |
| 5 |
Intel
INTC
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 9.63% |
| 5 | Energy | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Independent Bank
INDB
$3.94B
| $97.6K | ﹤0.01% |
+2,193
| New | +$114K |
|
1502
Assured Guaranty
AGO
$3.29B
| $95.2K | ﹤0.01% |
1,706
-2,919
| -63% | -$155K |
|
1503
Synchrony
SYF
$26B
| $94.8K | ﹤0.01% |
2,795
-439,245
| -99% | -$13.4M |
|
1504
Elastic
ESTC
$8.41B
| $93K | ﹤0.01% |
1,451
-106,363
| -99% | -$6.67M |
|
1505
N-able
NABL
$712M
| $92.8K | ﹤0.01% |
+6,442
| New | +$89.2K |
|
1506
CALL
Rivian
RIVN
$24.2B
| $90K | ﹤0.01% |
5,400
| – | – |
|
|
NUTX
1507
Nutex Health
NUTX
$1.25B
| $89.8K | ﹤0.01% |
1,420
+1,300
| +1,083% | +$111K |
|
1508
Affiliated Managers Group
AMG
$9.37B
| $89.3K | ﹤0.01% |
596
+26
| +5% | +$3.72K |
|
|
FITB
1509
PUT
Fifth Third Bancorp
FITB
$49.7B
| $89.1K | ﹤0.01% |
+3,400
| New | +$87.6K |
|
1510
Eagle Materials
EXP
$6.15B
| $88.9K | ﹤0.01% |
477
-4,449
| -90% | -$709K |
|
|
AKYA
1511
DELISTED
Akoya BioSciences
AKYA
| $88.7K | ﹤0.01% |
+12,000
| New | +$80.1K |
|
1512
Nexstar Media Group
NXST
$5.67B
| $87.5K | ﹤0.01% |
+526
| New | +$87.2K |
|
1513
Domo
DOMO
$177M
| $86.1K | ﹤0.01% |
5,875
-9,467
| -62% | -$140K |
|
1514
eBay
EBAY
$47.4B
| $85.9K | ﹤0.01% |
+1,923
| New | +$85.4K |
|
1515
Marriott Vacations Worldwide
VAC
$3.94B
| $85.7K | ﹤0.01% |
+698
| New | +$90.3K |
|
1516
CALL
Ovintiv
OVV
$18B
| $83.8K | ﹤0.01% |
2,200
| – | – |
|
1517
Expedia Group
EXPE
$40.3B
| $82.6K | ﹤0.01% |
755
-808,449
| -100% | -$79.2M |
|
1518
Ryder
R
$9.38B
| $81.3K | ﹤0.01% |
959
-320
| -25% | -$26.3K |
|
1519
Silicon Laboratories
SLAB
$7.27B
| $80.8K | ﹤0.01% |
512
-4,638
| -90% | -$701K |
|
1520
Valmont Industries
VMI
$9.19B
| $80.6K | ﹤0.01% |
+277
| New | +$80K |
|
1521
Cleveland-Cliffs
CLF
$6.53B
| $79.7K | ﹤0.01% |
4,752
-192,701
| -98% | -$3.06M |
|
1522
PROG Holdings
PRG
$1.54B
| $79K | ﹤0.01% |
+2,459
| New | +$74.1K |
|
1523
Taboola.com
TBLA
$989M
| $78.6K | ﹤0.01% |
25,268
+19,875
| +369% | +$54.5K |
|
|
RVNC
1524
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $78.5K | ﹤0.01% |
3,100
| – | – |
|
1525
Blue Bird Corp
BLBD
$1.88B
| $77.1K | ﹤0.01% |
+3,431
| New | +$73.4K |
|
Similar funds
Steven Cohen's Q2 2023 Portfolio in Review
As of Q2 2023, Steven Cohen held 2,962 positions worth $33.6B, up 4.1% from $32.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Steven Cohen withdrew a net $1.43B in Q2 2023, closing 858 positions and reducing 601 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Steven Cohen opened a new position in Micron Technology worth $178M.
- Steven Cohen's largest Q2 2023 buy was Micron Technology: 2,825,000 shares worth $178M.
- Steven Cohen added most to Microsoft in Q2 2023, an estimated $431M increase.
- Steven Cohen's biggest Q2 2023 reduction was Broadcom, cutting an estimated $459M.
- Steven Cohen fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $157M.
- Steven Cohen's ten largest holdings make up 14% of its $33.6B portfolio in Q2 2023.
- Steven Cohen opened 772 new positions and closed 858 in Q2 2023.
- Steven Cohen's portfolio value rose 4.1% quarter-over-quarter to $33.6B.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.